ANTIACIDE SUS 200 MG / 5 ML — DIN 00873470
ALUMINUM HYDROXIDE : 200 MG / 5 ML MAGNESIUM HYDROXIDE : 200 MG / 5 ML · PRODUITS MARC-O (1987) INC., DIVISION OF TECHNILAB INC. · SUSPENSION · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is ANTIACIDE SUS?
ANTIACIDE SUS 200 MG / 5 ML contains ALUMINUM HYDROXIDE : 200 MG / 5 ML MAGNESIUM HYDROXIDE : 200 MG / 5 ML. It is listed in the Health Canada Drug Product Database under DIN 00873470, held by PRODUITS MARC-O (1987) INC., DIVISION OF TECHNILAB INC., supplied as SUSPENSION for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 24-Aug-2000. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Ordinary Salt Combinations in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
26 holders have a Canadian DIN containing Ordinary Salt Combinations, across 43 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| RHONE-POULENC RORER CONSUMER INC. | 6 | 0 | MAALOX ANTACID CAPLETS, MAALOX SUSPENSION MINT FLAVOUR, MAALOX TABLET, MAALOX TABLETS CHERRY FLAVOUR, MAALOX TC SUSPENSION, +1 more | No marketed DIN |
| NOVARTIS CONSUMER HEALTH CANADA INC. | 4 | 0 | MAALOX SUSPENSION, MAALOX TABLETS, MAALOX TC SUSPENSION, MAALOX TC TABLET | No marketed DIN |
| AXCAN PHARMA INC | 3 | 0 | AMPHOJEL 500 SUSPENSION, AMPHOJEL PLUS SUSPENSION, AMPHOJEL PLUS TABLETS | No marketed DIN |
| STERLING WINTHROP INC. | 3 | 0 | GAVISCON ACID RELIEF FORMULA EXTRA STRENGTH, GAVISCON ACID RELIEF FORMULA LIQUID, GAVISCON ACID RELIEF FORMULA TABLETS | No marketed DIN |
| CARTER-HORNER CORP. | 2 | 0 | DIOVOL EX TAB, UNIVOL SUSPENSION | No marketed DIN |
| CIBA SELF MEDICATION | 2 | 0 | MAALOX TABLETS CHERRY FLAVOUR, MAALOX TABLETS MINT FLAVOUR | No marketed DIN |
| DESBERGERS LTÉE, DIVISION OF TECHNILAB INC. | 2 | 0 | NEUTRALCA S SUS, NEUTRALCA S TAB | No marketed DIN |
| PFIZER CANADA INC., CONSUMER HEALTHCARE DIVISION | 2 | 0 | GELUSIL LIQUID SUS, MYLANTA PLAIN LIQ DOUBLE STRENGTH SUS | No marketed DIN |
| WARNER-LAMBERT CANADA INC. | 2 | 0 | GELUSIL EXTRA STRENGTH LIQ, ROLAIDS EXTRA STRENGTH TAB | No marketed DIN |
| D.C. LABS LIMITED | 1 | 0 | ANTACID - ALUMINA AND MAGNESIA ORAL SUSPENSION USP | No marketed DIN |
| HERBES UNIVERSELLES INC. | 1 | 0 | GASULSOL TAB | No marketed DIN |
| KSL PHARMACEUTICALS | 1 | 0 | ANTACID SUS | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 200 MG / 5 ML |
|---|---|
| Dosage form | SUSPENSION |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Ordinary Salt Combinations |
|---|---|
| ATC code | A02AD01 |
| AHFS class | 56:04.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 00873470 |
|---|---|
| DIN (unpadded, as printed on some documents) | 873470 |
| Brand name | ANTIACIDE SUS |
| Generic / active ingredient | ALUMINUM HYDROXIDE : 200 MG / 5 ML MAGNESIUM HYDROXIDE : 200 MG / 5 ML |
| Market authorization holder | PRODUITS MARC-O (1987) INC., DIVISION OF TECHNILAB INC. |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A02AD01 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A02AD |
| Current status | CANCELLED POST MARKET |
| Status date | 24-Aug-2000 |
| Original market date | 1991-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
0 of 43 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACIDEX TC ORAL SUSPENSION | 600 MG / 5 ML | SUSPENSION | GEN DRUG COMPANY LTD. | CANCELLED POST MARKET | 00742309 |
| AMPHOJEL 500 SUSPENSION | 500 MG / 5 ML | SUSPENSION | AXCAN PHARMA INC | CANCELLED POST MARKET | 02125854 |
| AMPHOJEL PLUS SUSPENSION | 300 MG / 5 ML | SUSPENSION | AXCAN PHARMA INC | CANCELLED POST MARKET | 02125005 |
| AMPHOJEL PLUS TABLETS | 300 MG | TABLET | AXCAN PHARMA INC | CANCELLED POST MARKET | 02124998 |
| ANTACID | 174 MG / 5 ML | SUSPENSION | WES PAK PRODUCTS LTD. | CANCELLED POST MARKET | 02231621 |
| ANTACID - ALUMINA AND MAGNESIA ORAL SUSPENSION USP | 225 MG / 5 ML | SUSPENSION | D.C. LABS LIMITED | CANCELLED POST MARKET | 01927426 |
| ANTACID - TAB | 327.8 MG | TABLET | SWISS HERBAL REMEDIES LTD. | CANCELLED POST MARKET | 02217783 |
| ANTACID MAGNESIA AND ALUMINA | 200 MG / 5 ML | SUSPENSION | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | CANCELLED POST MARKET | 00854611 |
| ANTACID SUS | 200 MG / 5 ML | SUSPENSION | KSL PHARMACEUTICALS | CANCELLED POST MARKET | 00849138 |
| CENTRA ACID-SUS | 200 MG / 5 ML | SUSPENSION | THERAPEX DIVISION DE E-Z-EM CANADA INC | CANCELLED POST MARKET | 02141183 |
2 · Same class — other molecules in ATC A02AD
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Ordinary Salt Combinations | ACIDEX TC ORAL SUSPENSION · AMPHOJEL 500 SUSPENSION · AMPHOJEL PLUS SUSPENSION · AMPHOJEL PLUS TABLETS · +36 more | 43 | 0 | Not in Canada |
| Magaldrate | RIOPAN CHEWABLE TABLETS 480MG · RIOPAN SUS 480MG/5ML · RIOPAN SUSPENSION 480MG/5ML · RIOPAN TAB 480MG | 4 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC A02A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| A02AF | Magaldrate And Antiflatulents · Ordinary Salt Combinations And Antiflatulents | 59 | 4 |
| A02AX | Antacids, Other Combinations | 14 | 2 |
| A02AA | Magnesium Carbonate · Magnesium Hydroxide | 14 | 0 |
| A02AB | Aluminium Hydroxide | 1 | 0 |
| A02AC | Calcium Carbonate | 16 | 0 |
| A02AH | Antacids With Sodium Bicarbonate | 9 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.